Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT06856356

Clinical Efficacy and Safety of Robot-assisted Total Knee Arthroplasty

Led by The First Affiliated Hospital of University of Science and Technology of China · Updated on 2025-03-04

40

Participants Needed

1

Research Sites

195 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this clinical trial is to understand the application value of the Orthopedic Joint Surgery Navigation System in assisting surgeons to accurately place prosthetic components in adult knee replacement surgery. It will also confirm its effectiveness and safety in clinical application.

CONDITIONS

Official Title

Clinical Efficacy and Safety of Robot-assisted Total Knee Arthroplasty

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subjects voluntarily participate in the trial and sign the informed consent form
  • Aged 18 to 80 years old (inclusive), regardless of gender
  • Patients who need total knee replacement surgery
  • Those who can communicate well with the researchers and comply with the trial requirements
Not Eligible

You will not qualify if you...

  • Patients who are allergic to the drugs used in this trial or the implant materials
  • Patients with immature bone development
  • Patients with active infection
  • Patients with neuropathy of the knee joint
  • Patients with poor bone quality that is not conducive to prosthesis fixation
  • Patients with general conditions or concomitant diseases that make it difficult for people to tolerate surgery
  • Patients with insufficient quadriceps muscle strength
  • Patients with insufficient skin coverage near the surgical site and intolerance to surgery
  • Patients with severe femoral or tibial deformities and other severe deformities outside the joint
  • Patients with metal implants in the joint surgical area that affect the execution of the surgical plan
  • Pregnant or lactating women
  • Patients with severe epilepsy or mental illness
  • Patients with alcohol dependence or drug addiction
  • Patients with severe coagulation disorders
  • Patients who have participated in or are participating in other clinical trials within one month of enrollment
  • Patients who are considered by the researchers to be unsuitable for participating in this clinical trial for other reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

the first affiliated hospital of USTC

Hefei, Anhui, China, 230001

Actively Recruiting

Loading map...

Research Team

X

Xianzuo Zhang, Ph.D

CONTACT

X

Xianyue Shen, M.D

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here